BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 29691780)

  • 1. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
    Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M; Fukami T; Gotoh S; Nakajima M
    J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response.
    Yang CC; Chen YT; Chang YF; Liu H; Kuo YP; Shih CT; Liao WC; Chen HW; Tsai WS; Tan BC
    Cell Death Dis; 2017 May; 8(5):e2833. PubMed ID: 28542129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing.
    Khadka S; Williams CG; Sweeney-Gibbons J; Basler CF
    J Virol; 2021 Sep; 95(19):e0065221. PubMed ID: 34346762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic analysis of ADAR1 binding and its involvement in multiple RNA processing pathways.
    Bahn JH; Ahn J; Lin X; Zhang Q; Lee JH; Civelek M; Xiao X
    Nat Commun; 2015 Mar; 6():6355. PubMed ID: 25751603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
    Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
    J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding.
    Wang Q; Hui H; Guo Z; Zhang W; Hu Y; He T; Tai Y; Peng P; Wang L
    RNA; 2013 Nov; 19(11):1525-36. PubMed ID: 24067935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
    Sagredo EA; Blanco A; Sagredo AI; Pérez P; Sepúlveda-Hermosilla G; Morales F; Müller B; Verdugo R; Marcelain K; Harismendy O; Armisén R
    Biol Res; 2018 Oct; 51(1):36. PubMed ID: 30290838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing of
    Shiromoto Y; Sakurai M; Qu H; Kossenkov AV; Nishikura K
    RNA; 2020 Dec; 26(12):1801-1814. PubMed ID: 32817447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.
    Stellos K; Gatsiou A; Stamatelopoulos K; Perisic Matic L; John D; Lunella FF; Jaé N; Rossbach O; Amrhein C; Sigala F; Boon RA; Fürtig B; Manavski Y; You X; Uchida S; Keller T; Boeckel JN; Franco-Cereceda A; Maegdefessel L; Chen W; Schwalbe H; Bindereif A; Eriksson P; Hedin U; Zeiher AM; Dimmeler S
    Nat Med; 2016 Oct; 22(10):1140-1150. PubMed ID: 27595325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
    Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
    J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPEB3 suppresses gastric cancer progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies.
    Chen J; Li L; Liu TY; Fu HF; Lai YH; Lei X; Xu JF; Yu JS; Xia YJ; Zhang TH; Yang DJ; He YL
    Oncogene; 2022 Oct; 41(41):4591-4605. PubMed ID: 36068334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner.
    Chen T; Xiang JF; Zhu S; Chen S; Yin QF; Zhang XO; Zhang J; Feng H; Dong R; Li XJ; Yang L; Chen LL
    Cell Res; 2015 Apr; 25(4):459-76. PubMed ID: 25708366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
    Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
    RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A-to-I editing of coding and non-coding RNAs by ADARs.
    Nishikura K
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN.
    Park MJ; Jeong E; Lee EJ; Choi HJ; Moon BH; Kang K; Chang S
    Mol Cells; 2023 Jun; 46(6):351-359. PubMed ID: 36921992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells.
    Omata Y; Okawa M; Haraguchi M; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
    J Biol Chem; 2022 Aug; 298(8):102184. PubMed ID: 35753353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
    Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
    FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.